Related Experiment Video
Updated: Jun 24, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
[Immunisation schedule of the Pediatric Spanish Association: 2021 recommendations]
Francisco José Álvarez García1, María José Cilleruelo Ortega2, Javier Álvarez Aldeán3
1Centro de Salud de Llanera, Asturias, España; Departamento de Medicina, Universidad de Oviedo, Asturias, España.
Insights
The CAV-AEP recommends an updated childhood immunization schedule in Spain, including hexavalent, pneumococcal, rotavirus, meningococcal B and ACWY vaccines. Key updates include a 6-year booster, Tdap in pregnancy, and universal HPV vaccination for all genders.
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- The Spanish Association for the Prevention of Accidents (CAV-AEP) annually reviews and publishes optimal immunization schedules for children and adolescents in Spain.
- Evidence-based recommendations are crucial for maintaining high vaccination coverage and preventing vaccine-preventable diseases.
Purpose of the Study:
- To present the updated annual immunization schedule recommended by the CAV-AEP for children and adolescents in Spain.
- To outline specific vaccine recommendations, including schedules, age groups, and catch-up strategies.
Main Methods:
- The recommendations are based on the latest available scientific evidence and epidemiological data.
- The schedule incorporates routine vaccinations, booster doses, and specific vaccines for high-risk groups or travel indications.
Main Results:
- The recommended schedule includes a 2+1 schedule for hexavalent (DTPa-VPI-Hib-HB) and 13-valent pneumococcal conjugate vaccines.
- Key updates include a 6-year booster, Tdap vaccination in adolescents and during pregnancy, systematic rotavirus vaccination, and routine inclusion of Meningococcal B vaccine.
- The schedule also recommends Meningococcal ACWY vaccine at 12 months (replacing MenC) and 12 years, universal HPV vaccination regardless of gender at 12 years, and specific schedules for MMR and varicella vaccines.
Conclusions:
- The CAV-AEP's updated schedule aims to optimize protection against vaccine-preventable diseases in the Spanish pediatric population.
- Emphasis is placed on achieving high coverage for all recommended vaccines, including newly incorporated ones like HPV and Meningococcal B.
- The schedule provides a comprehensive framework for healthcare providers to ensure timely and complete immunization of children and adolescents.
Abstract:
The CAV-AEP annually publishes the immunisation schedule considered optimal for all children and adolescent resident in Spain, taking into account the available evidence. The 2+1 schedule is recommended (2, 4, and 11 months) with hexavalent vaccines (DTPa-VPI-Hib-HB) and with 13-valent pneumococcal conjugate.A 6-year booster is recommended, preferably with DTPa (if available), with a dose of polio for those who received 2+1 schemes, as well as vaccination with Tdpa in adolescents and in each pregnancy, preferably between 27 and 32 weeks. Rotavirus vaccine should be systematic for all infants. Meningococcal B vaccine, with a 2+1 schedule, should be included in routine calendar. In addition to the inclusion of the conjugated tetravalent meningococcal vaccine (MenACWY) at 12 years of age with catch up to 18 years, inclusive, the CAV recommends this vaccine to be also included at 12 months of age, replacing MenC. Likewise, it is recommended in those over 6 weeks of age with risk factors or who travel to countries with a high incidence of these serogroups. Two-dose schedules for triple viral (12 months and 3-4 years) and varicella (15 months and 3-4 years) will be used. The second dose could be applied as a tetraviral vaccine. Universal systematic vaccination against HPV is recommended, regardless of gender, preferably at 12 years, and greater effort should be made to improve coverage. The 9 genotype extends coverage for both genders.
More Related Videos
Related Concept Videos
Vaccinations
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion
Vaccines

